Effect of Extending the Duration of Prequit Treatment With Varenicline on Smoking Abstinence is a research paper published in JAMA Network Open (2022). On theSindex it has a DataRank of 0.354. It has been cited 8 times, with 2 citing works in its 1-hop citation network.
Scored on demand from live citation data
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.330
From this paper's citation signal
Citation Network Contribution
0.0239
From 1 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 2 citers.
National Institutes of Health
Grant: 5UL1TR002001-08
The University of Rochester Clinical and Translational Science Award Hub
National Institutes of Health
Grant: 1R01CA206193-01A1
EVarQuit: Extinguishing cigarette smoking via extended pre-quit varenicline
National Institutes of Health
Grant: 3UL1TR001412-08S3
Buffalo Clinical and Translational Research Center
Canadian Institutes of Health Research
Grant: unidentified
unidentified
FWCI
0.88
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals